European Urology Oncology

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Volume 72, Issue 3, Pages (September 2017)
An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer  Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco.
Volume 68, Issue 6, Pages (December 2015)
Volume 61, Issue 3, Pages (March 2012)
Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction? 
Volume 62, Issue 3, Pages (September 2012)
Volume 155, Issue 3, Pages (March 1996)
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for.
Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.
Volume 62, Issue 4, Pages (October 2012)
Volume 58, Issue 1, Pages (July 2010)
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer  Francesco Cantiello, Giorgio.
European Urology Oncology
Volume 49, Issue 2, Pages (February 2006)
Volume 61, Issue 5, Pages (May 2012)
Volume 51, Issue 6, Pages (June 2007)
Volume 53, Issue 5, Pages (May 2008)
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 
Volume 51, Issue 3, Pages (March 2007)
Volume 73, Issue 3, Pages (March 2018)
European Urology Oncology
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis  Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,
Volume 52, Issue 4, Pages (October 2007)
Volume 63, Issue 6, Pages (June 2013)
Volume 56, Issue 3, Pages (September 2009)
Volume 63, Issue 4, Pages (April 2013)
European Urology Oncology
Volume 67, Issue 4, Pages (April 2015)
Volume 68, Issue 5, Pages (November 2015)
Nomograms for Bladder Cancer
Volume 67, Issue 2, Pages (February 2015)
Volume 74, Issue 2, Pages (August 2018)
Volume 67, Issue 3, Pages (March 2015)
Volume 57, Issue 4, Pages (April 2010)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
European Urology Oncology
Volume 61, Issue 3, Pages (March 2012)
Volume 61, Issue 5, Pages (May 2012)
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Volume 70, Issue 6, Pages (December 2016)
Volume 59, Issue 1, Pages (January 2011)
Volume 60, Issue 6, Pages (December 2011)
Volume 56, Issue 5, Pages (November 2009)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
Prostate Cancer Nomograms: An Update
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA  Nawar Hanna, Quoc-Dien Trinh,
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of.
European Urology Oncology
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder  Devin N. Patel, Michael Luu, Zachary.
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Volume 50, Issue 5, Pages (November 2006)
Axel Heidenreich  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
European Urology Oncology
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection.
Fernando P. Secin, Fernando J. Bianco, Nicholas T
European Urology Oncology
Oncoforum Urology: Prostate Cancer 2008 at a Glance
European Urology Oncology
Axel Heidenreich  European Urology Supplements 
European Urology Oncology
European Urology Oncology
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
European Urology Oncology
Kaplan-Meier (K-M) curves of progression-free survival (PFS) in 54 patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier (K-M) curves.
Presentation transcript:

European Urology Oncology The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes  Elio Mazzone, Felix Preisser, Sebastiano Nazzani, Zhe Tian, Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, Markus Graefen, Shahrokh F. Shariat, Fred Saad, Alberto Briganti, Pierre I. Karakiewicz  European Urology Oncology  DOI: 10.1016/j.euo.2018.10.010 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 IPTW-adjusted Kaplan-Meier plots depicting (A) CSM-free and (B) OM-free survival of 330 patients with newly diagnosed metastatic prostate cancer who underwent radical prostatectomy, stratified according to the presence or absence of lymph node dissection. CSM=cancer-specific mortality; IPTW=inverse probability of treatment weighting; LND=lymph node dissection; OM=overall mortality. European Urology Oncology DOI: (10.1016/j.euo.2018.10.010) Copyright © 2018 European Association of Urology Terms and Conditions